DR

Dr. Rosell Oncology Institute, Dexeus University Hospital at PEGS Europe 2026

Nov 16–19, 2026 Lisbon, Portugal ~1.5k attendees Website

Dr. Rosell Oncology Institute, Dexeus University Hospital brings 2 presentations to PEGS Europe 2026 in Lisbon. Its program centres on clinical outcomes in immunotherapy. It reports an early-phase trial giving cemiplimab with imiquimod and laser therapy before surgery to people with high-risk basal cell carcinoma.

OrganizationPEGS Europe 2026 Attendance
DR
Dr. Rosell Oncology Institute, Dexeus University Hospital
Barcelona, Spain
Talk
Thu Nov 19
11:15am–11:45am
Panel
Thu Nov 19
3:35pm–4:15pm
Clinical Outcomes in Immunotherapy—Where Are We Now?
Next-Generation Immunotherapies · with Accession Therapeutics, BioInvent, Immatics +2 more

Explore the full PEGS Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Lisbon. Leave your work email and we’ll be in touch.

Privacy

Download the full PEGS Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Dr. Rosell Oncology Institute, Dexeus University Hospital

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by PEGS Europe or its organizers. Submit a correction